Search
-
News
These special awards are presented to researchers and global oncology leaders who have reshaped cancer care around the world and are among the highest honors bestowed by ASCO.
… Tuesday, March 29, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Fumiko Chino, MD; Craig B. Thompson, MD; and Jedd D. Wolchok, MD, PhD, FASCO, have been honored by the American Society of Clinical Oncology (ASCO) and Conquer Cancer, the ASCO Foundation, with three prestigious
-
News
CyberKnife is a brand name for one of several available stereotactic radiosurgery devices that deliver radiation with linear accelerators. MSK uses a similar device, made by a company called Varian, that destroys tumors with extremely precise, very intense doses of radiation.
… Monday, February 24, 2014 Summary CyberKnife is a brand name. It refers to a stereotactic body radiation therapy device that delivers radiation using advanced imaging technology. MSK uses similar technology as part of an approach called MSK Precise TM . This method destroys tumors with very intense doses
-
News
Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.
… Wednesday, August 8, 2018 Summary MSK experts say we don’t yet have enough information about kratom to know whether it is safe and effective for people with cancer. In the past few years, a number of companies in the United States have begun selling an herbal product called kratom, mostly online. The
-
News
A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.
… Monday, June 22, 2015 Summary A growing community of Memorial Sloan Kettering scientists are doing research into epigenetics — an intricate system of biochemical adjustments that cells use to regulate genes — to improve our understanding of cancer and other diseases. One of these researchers is Mingkui
-
MSK News
A visionary program investigates how the body’s ecosystem affects cancer.
… Friday, April 1, 2022 Dear MSK Community, We are poised at a pivotal moment in cancer research. For the past few decades, researchers have focused on identifying gene mutations associated with cancer and have developed highly effective drugs to target them. This revolutionary approach, called precision
-
News
Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy.
… Friday, June 28, 2019 Temozolomide chemotherapy reduced seizures in 90 percent of patients with World Health Organization (WHO) grade 2 oligodendroglioma and tumor-related epilepsy, according to the results of a recent retrospective study of 39 patients treated at Memorial Sloan Kettering Cancer Center
-
Newsroom
The success of science, research, and medicine in saving and extending lives requires the transfer of ideas and knowledge in the laboratory, classroom, hospitals and clinics. The Executive Order issued on June 22 that suspends the issuing of temporary visas for certain foreign workers will only impede the innovation and scientific leadership that the world has come to expect from the United States.
… Wednesday, June 24, 2020 The success of science, research, and medicine in saving and extending lives requires the transfer of ideas and knowledge in the laboratory, classroom, hospitals and clinics. Shutting off access to the brightest and most talented scientists and clinicians from around the world
-
News
Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment.
… Tuesday, March 8, 2022 An Advocate for Patients with Cancer As a registered nurse for the past 13 years, Karen Granville , who now serves as a Nurse Case Manager for Patient Financial Services at MSK, empathizes with the struggles faced by our patients with cancer. “It’s easy to lose hope,” Ms. Granville
-
News
Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital, a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing cancer program at the C. Anthony and Jean Whittingham Cancer Center at Norwalk Hospital.
… Monday, October 16, 2017 Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital , a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing cancer program at the C. Anthony
-
News
The third annual research symposium introduces high school students and teachers to several topics in cancer research.
… Sunday, March 1, 2009 Summary The third annual research symposium introduces high school students and teachers to several topics in cancer research. An important part of Memorial Sloan Kettering’s mission has always been education. As part of that goal, an annual symposium called Major Trends in Modern